Background: Antigametocyte-specific immune responses may regulate Plasmodium falciparum gametocyte density, providing the rationale for pursuing transmission-blocking vaccines (TBVs) that target gametocytes in the human host. Methods: To identify novel antigametocyte TBV antigens, we interrogated the gametocyte proteome with our whole proteome differential screening method using plasma from a treatment-reinfection study conducted in western Kenya. At the start of the high-transmission season, 144 males (12-35 years) were enrolled and treated with quinine and doxycycline, peripheral venous blood samples were obtained, volunteers were observed, and weekly blood films were obtained for 18 weeks to quantify gametocytemia. Using plasma pooled from individuals with low versus high gametocyte carriage, we differentially screened a P falciparum gametocyte stage complementary deoxyribonucleic acid expression library. Results: We identified 8 parasite genes uniquely recognized by gametocyte-resistant but not by gametocyte-susceptible individuals. Antibodies to one of these antigens, PfsEGXP, predicted lower gametocytemia measured over the 18-week transmission season (P = .021). When analyzed dichotomously, anti-PfsEGXP responders had 31% lower gametocyte density over 18 weeks of follow-up, compared with nonresponders (P = .04). Conclusions: PfsEGXP is one of the first reported gametocyte-specific target of antibodies that predict decreased gametocyte density in humans and supports our novel TBV antigen discovery platform.
Background: Antigametocyte-specific immune responses may regulate Plasmodium falciparum gametocyte density, providing the rationale for pursuing transmission-blocking vaccines (TBVs) that target gametocytes in the human host. Methods: To identify novel antigametocyte TBV antigens, we interrogated the gametocyte proteome with our whole proteome differential screening method using plasma from a treatment-reinfection study conducted in western Kenya. At the start of the high-transmission season, 144 males (12-35 years) were enrolled and treated with quinine and doxycycline, peripheral venous blood samples were obtained, volunteers were observed, and weekly blood films were obtained for 18 weeks to quantify gametocytemia. Using plasma pooled from individuals with low versus high gametocyte carriage, we differentially screened a P falciparum gametocyte stage complementary deoxyribonucleic acid expression library. Results: We identified 8 parasite genes uniquely recognized by gametocyte-resistant but not by gametocyte-susceptible individuals. Antibodies to one of these antigens, PfsEGXP, predicted lower gametocytemia measured over the 18-week transmission season (P = .021). When analyzed dichotomously, anti-PfsEGXP responders had 31% lower gametocyte density over 18 weeks of follow-up, compared with nonresponders (P = .04). Conclusions: PfsEGXP is one of the first reported gametocyte-specific target of antibodies that predict decreased gametocyte density in humans and supports our novel TBV antigen discovery platform.
Authors: Francesco Silvestrini; Edwin Lasonder; Anna Olivieri; Grazia Camarda; Ben van Schaijk; Massimo Sanchez; Sumera Younis Younis; Robert Sauerwein; Pietro Alano Journal: Mol Cell Proteomics Date: 2010-03-22 Impact factor: 5.911
Authors: Dipak K Raj; Christian P Nixon; Christina E Nixon; Jeffrey D Dvorin; Christen G DiPetrillo; Sunthorn Pond-Tor; Hai-Wei Wu; Grant Jolly; Lauren Pischel; Ailin Lu; Ian C Michelow; Ling Cheng; Solomon Conteh; Emily A McDonald; Sabrina Absalon; Sarah E Holte; Jennifer F Friedman; Michal Fried; Patrick E Duffy; Jonathan D Kurtis Journal: Science Date: 2014-05-23 Impact factor: 47.728
Authors: R Price; F Nosten; J A Simpson; C Luxemburger; L Phaipun; F ter Kuile; M van Vugt; T Chongsuphajaisiddhi; N J White Journal: Am J Trop Med Hyg Date: 1999-06 Impact factor: 2.345
Authors: Marta Ponzi; Inga Sidén-Kiamos; Lucia Bertuccini; Chiara Currà; Hans Kroeze; Grazia Camarda; Tomasino Pace; Blandine Franke-Fayard; Eliane C Laurentino; Christos Louis; Andrew P Waters; Chris J Janse; Pietro Alano Journal: Cell Microbiol Date: 2009-04-30 Impact factor: 3.715
Authors: Pedro L Alonso; Graham Brown; Myriam Arevalo-Herrera; Fred Binka; Chetan Chitnis; Frank Collins; Ogobara K Doumbo; Brian Greenwood; B Fenton Hall; Myron M Levine; Kamini Mendis; Robert D Newman; Christopher V Plowe; Mario Henry Rodríguez; Robert Sinden; Laurence Slutsker; Marcel Tanner Journal: PLoS Med Date: 2011-01-25 Impact factor: 11.069
Authors: Laura Grange; Cheikh Loucoubar; Olivier Telle; Adama Tall; Joseph Faye; Cheikh Sokhna; Jean-François Trape; Anavaj Sakuntabhai; Jean-François Bureau; Richard Paul Journal: PLoS One Date: 2015-04-01 Impact factor: 3.240
Authors: Riward A Campelo Morillo; Xinran Tong; Wei Xie; Steven Abel; Lindsey M Orchard; Wassim Daher; Dinshaw J Patel; Manuel Llinás; Karine G Le Roch; Björn F C Kafsack Journal: Nat Microbiol Date: 2022-01-27 Impact factor: 30.964